News
RVVTF
0.018
+0.55%
0.000
Weekly Report: what happened at RVVTF last week (0428-0502)?
Weekly Report · 6d ago
Weekly Report: what happened at RVVTF last week (0421-0425)?
Weekly Report · 04/28 10:44
Revive Therapeutics Announces Shares for Debt Transaction to Preserve Cash
TipRanks · 04/21 21:07
Revive Therapeutics Announces Proposed Shares for Debt Transaction
Barchart · 04/21 15:30
Weekly Report: what happened at RVVTF last week (0414-0418)?
Weekly Report · 04/21 10:44
Weekly Report: what happened at RVVTF last week (0407-0411)?
Weekly Report · 04/14 10:37
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
TipRanks · 04/10 15:05
Revive Therapeutics Explores Bucillamine’s Role in Cancer Treatment
TipRanks · 04/10 11:39
Weekly Report: what happened at RVVTF last week (0331-0404)?
Weekly Report · 04/07 10:36
Revive Therapeutics Expands Pipeline with Molecular Hydrogen Acquisition
TipRanks · 04/01 12:11
Revive enters asset purchase agreement for molecular hydrogen program
TipRanks · 04/01 11:45
Weekly Report: what happened at RVVTF last week (0324-0328)?
Weekly Report · 03/31 10:44
Weekly Report: what happened at RVVTF last week (0317-0321)?
Weekly Report · 03/24 10:36
REVIVE THERAPEUTICS ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING
Reuters · 03/19 13:14
Weekly Report: what happened at RVVTF last week (0310-0314)?
Weekly Report · 03/17 10:43
Weekly Report: what happened at RVVTF last week (0303-0307)?
Weekly Report · 03/10 10:45
Revive Therapeutics to Acquire DiagnaMed’s Molecular Hydrogen Program for Neurological Treatments
TipRanks · 03/03 13:44
Revive Therapeutics enters LOI to acquire DiagnaMed’s molecular hydrogen program
TipRanks · 03/03 13:22
Weekly Report: what happened at RVVTF last week (0224-0228)?
Weekly Report · 03/03 10:44
Weekly Report: what happened at RVVTF last week (0217-0221)?
Weekly Report · 02/24 10:44
More
Webull provides a variety of real-time RVVTF stock news. You can receive the latest news about Revive Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RVVTF
More
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
Recently
Symbol
Price
%Change